Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THE CHEMOURS COMPANY

(CC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Chemours : UBS Adjusts Chemours' Price Target to $36 From $34, Maintains Neutral Rating

07/30/2021 | 11:01am EDT


ę MT Newswires 2021
All news about THE CHEMOURS COMPANY
10/26CHEMOURS CO Change in Directors or Principal Officers (form 8-K/A)
AQ
10/22CHEMOURS : Named Champion of Board Diversity by The Forum of Executive Women
PU
10/17CHEMOURS : Traversing Obviousness Rejections
AQ
10/14CHEMOURS : Announces Dates for Third Quarter 2021 Earnings Release and Webcast Conference ..
PR
10/08CHEMOURS CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
AQ
10/06CHEMOURS : Renews NHL Partnership to Provide Environmentally Sustainable Refrigerant Servi..
MT
10/06CHEMOURS : NHL and Chemours Announce Multiyear Partnership Renewal, Expanding Successful C..
PR
10/06The National Hockey League and The Chemours Company Announces Multiyear Renewal of Part..
CI
10/04CHEMPOINT : Ti-Pure
AQ
09/29CHEMOURS CO : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Analyst Recommendations on THE CHEMOURS COMPANY
More recommendations
Financials (USD)
Sales 2021 6 130 M - -
Net income 2021 482 M - -
Net Debt 2021 2 669 M - -
P/E ratio 2021 10,2x
Yield 2021 3,43%
Capitalization 4 781 M 4 781 M -
EV / Sales 2021 1,22x
EV / Sales 2022 1,09x
Nbr of Employees 6 500
Free-Float 85,7%
Chart THE CHEMOURS COMPANY
Duration : Period :
The Chemours Company Technical Analysis Chart | CC | US1638511089 | MarketScreener
Technical analysis trends THE CHEMOURS COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 28,95 $
Average target price 40,25 $
Spread / Average Target 39,0%
EPS Revisions
Managers and Directors
Mark E. Newman President, CEO, COO, Director & Senior VP
Sameer Ralhan Chief Financial Officer & Senior Vice President
Mark P. Vergnano Chairman
Randal King VP-Technology & Advanced Performance Materials
Curtis V. Anastasio Independent Director
Sector and Competitors